Target intelligence / Profile preview

Lysosomal pathway

Molecular classification
Other (cellular process), Organelle-associated process, Degradation pathway, Not a single molecule or receptor
01

Overview

The *lysosomal pathway* refers broadly to the set of cellular processes involving lysosomes—membrane-bound organelles that function as the digestive system of eukaryotic cells. Lysosomes degrade material taken up from outside via endocytosis and phagocytosis as well as obsolete intracellular components through autophagy. They contain over 50 types of acid hydrolase enzymes active in an acidic environment maintained by proton pumps in their membranes. The breakdown products are recycled for biosynthesis and energy production. The proper functioning of this system is essential for cellular homeostasis, immune defense via antigen processing/presentation, metabolic regulation through nutrient sensing and mTOR signaling integration, and programmed cell death when necessary[1][2][4][5]. Dysfunction in any part can contribute to diseases including neurodegeneration, cancer progression/resistance mechanisms,[8] autoimmune conditions,[6] and infectious diseases. **Note:** "Lysosomal pathway" is not a canonical name for a single molecule/receptor but rather describes an interconnected network/process involving many molecules—primarily enzymes like cathepsins; transporters like V-type ATPases; channels such as TRPMLs; membrane proteins like LAMPs; regulatory complexes including mTORC1—and thus does **not** fit standard definitions for therapeutic targets such as receptors or enzymes themselves. For structured data purposes it should be flagged as incorrect if used where a discrete molecular entity is required.

Other names
Lysosome pathwayLysosomal degradation pathwayAutophagy-lysosomal pathway
02

Biological functions

Intracellular digestionDegradation of macromoleculesAutophagyPhagocytosisEndocytosis processingImmune response (antigen presentation)Cell death (lysosome-mediated programmed cell death)Cellular metabolism regulation[1][2][4][5]
03

Disease associations

Neurodegenerative disease (e.g., lysosomal storage disorders)Cancer[8]Autoimmune disease[6]Infection/Immunity[2]

Beyond the preview

Go deeper on Lysosomal pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosomal pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call